| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830271242 |
| P8608 | Fatcat ID | release_bu3c2jyekfbptp3b4xpxmgn24a |
| P698 | PubMed publication ID | 9464831 |
| P2093 | author name string | Zimmermann S | |
| Bauer M | |||
| Heeg K | |||
| Wagner H | |||
| Lipford GB | |||
| Sparwasser T | |||
| Koch ES | |||
| P2860 | cites work | Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines | Q72641753 |
| CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants | Q73814892 | ||
| Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages | Q29618421 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Methylation of integrated adenovirus type 12 DNA sequences in transformed cells is inversely correlated with viral gene expression | Q34251467 | ||
| CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
| The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
| Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
| Immunology of leishmaniasis | Q35266044 | ||
| Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization | Q36356200 | ||
| Recombinant interleukin 12 cures mice infected with Leishmania major | Q36361742 | ||
| High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
| Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein | Q38347420 | ||
| Current status of immunological adjuvants | Q39441408 | ||
| The B7 and CD28 receptor families | Q40392461 | ||
| Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin | Q40402483 | ||
| The regulation of immunity to Leishmania major | Q40444839 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Immune activation by bacterial DNA: a new genetic code | Q41182494 | ||
| Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells | Q41496102 | ||
| Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock | Q44931090 | ||
| Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. | Q45978807 | ||
| Bacterial DNA causes septic shock | Q59065014 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3420-3426 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines | |
| P478 | volume | 27 |
| Q57842251 | A Trypanosoma cruzi Alkaline Antigen Induces Polyclonal B-Cell Activation of Normal Murine Spleen Cells by T-Cell-Independent, BCR-Directed Stimulation |
| Q35960520 | A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice |
| Q43604612 | A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major |
| Q34465399 | A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection |
| Q34005473 | Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety |
| Q36021357 | Adjuvants for Leishmania vaccines: from models to clinical application |
| Q35826747 | Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators |
| Q33597488 | Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants |
| Q33683211 | Bacterial CpG DNA activates immune cells to signal infectious danger. |
| Q35596596 | Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. |
| Q77385466 | Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells |
| Q39836774 | Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis |
| Q33367582 | Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements |
| Q43459073 | Confrontation between intracellular bacteria and the immune system. |
| Q73042328 | CpG DNA as mucosal adjuvant |
| Q40790193 | CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. |
| Q46796731 | CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in mice |
| Q38321323 | CpG motifs in Porphyromonas gingivalis DNA stimulate interleukin-6 expression in human gingival fibroblasts. |
| Q33843264 | CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice |
| Q54021251 | CpG-DNA upregulates the major acute-phase proteins SAA and SAP. |
| Q38331783 | CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation |
| Q33647526 | CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. |
| Q63407133 | CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12 |
| Q49048846 | CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. |
| Q35543857 | Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice |
| Q78157796 | DNA activates human immune cells through a CpG sequence-dependent manner |
| Q33783789 | DNA and RNA-based vaccines: principles, progress and prospects |
| Q34581285 | DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cells |
| Q90270024 | DNA-Based Biomaterials for Immunoengineering |
| Q77930082 | DNA-antiviral vaccines: new developments and approaches--a review |
| Q37412987 | DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component |
| Q35597705 | Detection and identification of bacterial DNA in serum from patients with acute pancreatitis |
| Q43580300 | Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships |
| Q35622458 | Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-gamma on protective immunity by a DNA vaccine against IBDV in chickens |
| Q34540279 | Effects of particle size on toll-like receptor 9-mediated cytokine profiles |
| Q37419135 | Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas |
| Q57258512 | Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo |
| Q34009831 | Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages |
| Q33930537 | Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition |
| Q83295610 | IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses |
| Q80997381 | Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells |
| Q34778728 | Immunization of aged pigs with attenuated pseudorabies virus vaccine combined with CpG oligodeoxynucleotide restores defective Th1 immune responses |
| Q37419697 | Immunomodulatory consequences of ODN CpG-polycation complexes |
| Q35009277 | Immunopharmacology of CpG DNA. |
| Q35206358 | Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer |
| Q34001298 | Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. |
| Q34005429 | Immunostimulatory DNA sequences and cancer therapy |
| Q38131836 | Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species |
| Q45090402 | Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. |
| Q34798245 | In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs - a pilot study |
| Q33576071 | In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model |
| Q34340988 | Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes |
| Q40483387 | Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. |
| Q73256317 | Influence of backbone chemistry on immune activation by synthetic oligonucleotides |
| Q43926940 | Innate IL-10 promotes the induction of Th2 responses with plasmid DNA expressing HIV gp120. |
| Q40628602 | Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity |
| Q34005376 | Introduction to immunostimulatory DNA sequences |
| Q54540731 | Lipid-mediated delivery of oligonucleotide to pulmonary endothelium. |
| Q73019275 | Lipid-mediated delivery of peptide nucleic acids to pulmonary endothelium |
| Q45534569 | Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant |
| Q34005382 | Mechanisms of immune stimulation by bacterial DNA. |
| Q46712016 | Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins |
| Q37818335 | Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines |
| Q34023547 | Nucleic acid vaccines: research tool or commercial reality |
| Q34941937 | Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection |
| Q35949884 | Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase |
| Q34164404 | Plasmacytoid dendritic cells: the key to CpG. |
| Q77148378 | Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines |
| Q40851955 | Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokines |
| Q38306977 | Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens |
| Q40493750 | Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB. |
| Q44290955 | Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides |
| Q34005396 | Rescue of B cells from apoptosis by immune stimulatory CpG DNA. |
| Q38218115 | Role of toll-like receptors in immune activation and tolerance in the liver |
| Q36122395 | Synthetic mimics of antimicrobial peptides with immunomodulatory responses |
| Q34123358 | The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin |
| Q73781377 | The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines |
| Q34721762 | The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release |
| Q73537468 | The effects of DNA containing CpG motif on dendritic cells |
| Q54635817 | The in vitro effects of CpG oligodeoxynucleotides on the expression of cytokine genes in the common carp (Cyprinus carpio L.) head kidney cells. |
| Q40107397 | Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours |
| Q81151049 | Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis |
| Q53949766 | Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. |
| Q45408262 | Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets |
Search more.